sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
23-May-2015 11:00
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 701-725 out of 1032.

<< < 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 > >>

Public Release: 17-Mar-2014
Journal of Biological Chemistry
New therapeutic target identified for acute lung injury
A bacterial infection can throw off the equilibrium between two key proteins in the lungs and put patients at risk for a highly lethal acute lung injury, researchers report.
National Institutes of Health

Contact: Toni Baker
Medical College of Georgia at Georgia Regents University

Public Release: 14-Mar-2014
School sick days could be reduced with safe drinking water
Providing free drinking water in schools could be key to helping people in developing countries lift themselves out of poverty according to research from the University of East Anglia. New research shows that schools providing clean water report fewer children off sick. It is the first study to investigate whether providing drinking water in schools can reduce absenteeism.

Contact: Lisa Horton
University of East Anglia

Public Release: 13-Mar-2014
Innovative solar-powered toilet developed by CU-Boulder ready for India unveiling
A revolutionary University of Colorado Boulder toilet fueled by the sun that is being developed to help some of the 2.5 billion people around the world lacking safe and sustainable sanitation will be unveiled in India this month.
Bill and Melinda Gates Foundation

Contact: Karl Linden
University of Colorado at Boulder

Public Release: 12-Mar-2014
Second largest research award at Notre Dame fights malaria and dengue fever
Notre Dame biologists Nicole Achee and Neil Lobo are leaders of an international $23 million research grant from the Bill & Melinda Gates Foundation. Their five-year project will generate the data required to show the effectiveness of a new paradigm in mosquito control -- spatial repellency -- for the prevention of two important mosquito-borne diseases: malaria and dengue fever.
Bill and Melinda Gates Foundation

Contact: william gilroy
University of Notre Dame

Public Release: 11-Mar-2014
Novel vaccine trial design aims to answer key TB questions
Aeras today announced the initiation of the first randomized, controlled tuberculosis vaccine trial designed to study prevention of Mycobacterium tuberculosis infection by vaccination.

Contact: Annmarie Leadman

Public Release: 9-Mar-2014
Eye health experts come together to boost fight against avoidable blindness
On Commonwealth Day, a new £7.1 million grant has established the Commonwealth Eye Health Consortium. Coordinated by the International Centre for Eye Health at the London School of Hygiene & Tropical Medicine, the Consortium will pursue vital research into conditions such as diabetic retinopathy which leave millions without sight, and will build capacity across the Commonwealth to tackle avoidable blindness and provide quality care to those affected or at risk.
The Queen Elizabeth Diamond Jubilee Trust

Contact: Katie Steels
London School of Hygiene & Tropical Medicine

Public Release: 7-Mar-2014
Education 'protects' poor women from fattening effects of rising wealth
Obesity levels among women in low- and middle-income countries tend to rise in line with wealth as they purchase more energy-dense foods, but a new UCL study suggests that more educated consumers make better food choices that mitigate this effect. The study showed that in middle-income countries, obesity levels among women with secondary or higher education are 14-19 percent lower than less-educated women of similar wealth.

Contact: Harry Dayantis
University College London

Public Release: 6-Mar-2014
Warmer temperatures push malaria to higher elevations
Researchers have debated for more than two decades the likely impacts, if any, of global warming on the worldwide incidence of malaria, a mosquito-borne disease that infects more than 300 million people each year.

Contact: Jim Erickson
University of Michigan

Public Release: 6-Mar-2014
PLOS Pathogens
Drug protects mice against malaria brain damage, raises levels of BDNF in humans
Cerebral malaria is a serious complication of infection with the malaria parasite, affecting approximately one in a thousand children in areas where malaria is common. Many of the patients die, and among those who survive, about a third have lasting cognitive and neurological disabilities, including epilepsy and learning disorders. A study published on March 6 in PLOS Pathogens shows that a known drug can prevent brain damage in a cerebral malaria mouse model and eliminate subsequent neurological deficits.

Contact: Lena Serghides

Public Release: 4-Mar-2014
21st Conference on Retroviruses and Opportunistic Infections
Two studies advance HIV prevention options for women
Two early clinical studies of novel HIV prevention products for women -- the first combination antiretroviral vaginal ring and a vaginal film -- show the products to be safe and open the door to product improvements that could expand options for women-initiated prevention tools. The results of both studies were presented today at the 21st Conference on Retroviruses and Opportunistic Infections.

Contact: Holly Seltzer
International Partnership for Microbicides (IPM)

Public Release: 4-Mar-2014
Global Public Health
Fighting against HIV in the Central African Republic -- the importance of perseverance
According to Pierre-Marie David of the University of Montreal's Faculty of Pharmacy, stock-outs of antiretroviral drugs in recent years in the Central African Republic have had a dramatic impact on the health of HIV-infected people. These shortages have also created mistrust among patients toward the political and medical actors responsible for the fight against HIV/AIDS.
Méos, SIDAction

Contact: William Raillant-Clark
University of Montreal

Public Release: 3-Mar-2014
New constipation treatment under study for Parkinson's patients
Constipation can be another uncomfortable problem for patients with Parkinson's disease that standard treatment won't relieve, researchers say.

Contact: Toni Baker
Medical College of Georgia at Georgia Regents University

Public Release: 3-Mar-2014
Novel drug treatment protects primates from deadly Marburg virus
For the first time, scientists have demonstrated the effectiveness of a small-molecule drug in protecting nonhuman primates from the lethal Marburg virus. Their work, published online in the journal Nature, is the result of a continuing collaboration between Army scientists and industry partners that also shows promise for treating a broad range of other viral diseases.
Joint Science and Technology Office for Chemical and Biological Defense, Defense Threat Reduction Agency

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 3-Mar-2014
New research on potent HIV antibodies has opened up possibilities
The discovery of how a KwaZulu-Natal woman's body responded to her HIV infection by making potent antibodies (called broadly neutralizing antibodies, because they are able to kill multiple strains of HIV from across the world), was reported today by the CAPRISA consortium of AIDS researchers jointly with scientists from the United States.

Contact: Vivienne Rowland
University of the Witwatersrand

Public Release: 3-Mar-2014
Europe is joining forces against neglected parasitic diseases
The international consortium A-PARADDISE (Anti-Parasitic Drug Discovery in Epigenetics), coordinated by Inserm, has just obtained funds of €6 million from the European Commission to conduct large-scale testing of innovative therapies against four neglected parasitic diseases: schistosomiasis, leishmaniasis, Chagas disease and malaria. The researchers have a common objective: to develop new drugs against the parasites that cause these diseases.
European Commission

Contact: Raymond Pierce
INSERM (Institut national de la santé et de la recherche médicale)

Public Release: 28-Feb-2014
Journal of Virology
Light zaps viruses: How photosensitization can stop viruses from infecting cells
Researchers find evidence that photosensitizing a virus's membrane covering can inhibit its ability to enter cells and potentially lead to the development of stronger, cheaper medications to fight a host of tough viruses.
National Institutes of Health, Fundação para a Ciência e a Tecnologia

Contact: Enrique Rivero
University of California - Los Angeles Health Sciences

Public Release: 28-Feb-2014
PLOS Neglected Tropical Diseases
Indonesia's competitiveness at risk from neglected diseases of poverty
Indonesia has seen impressive economic and development growth. Sustaining these gains, however, may not be possible without aggressively addressing neglected tropical diseases, which affect the majority of Indonesians. Neglected tropical diseases are 'one of the most potent forces' of extreme poverty and inequality in Indonesia, Dr. Peter Hotez, president of the Sabin Vaccine Institute, and Dr. Lorenzo Savioli, director of the Department of Control of Neglected Tropical Diseases at the World Health Organization, among others, explain in PLOS Neglected Tropical Diseases.

Contact: Deborah Elson
Sabin Vaccine Institute

Public Release: 27-Feb-2014
New research to revolutionize healthcare through remote monitoring of patients
Researchers from the University of Surrey have today launched a new program of research called eSMART (Electronic Symptom Management using ASyMS Remote Technology), that uses mobile phone technology to remotely monitor patients who are undergoing chemotherapy to treat breast, bowel and blood cancers. A €6 million grant from the European Union will fund a large 1,000 patient trial in England, Austria, Greece, Holland, Ireland and Norway, with the hope that the new system will be integrated into routine cancer care in the future.
European Union

Contact: Peter La
University of Surrey

Public Release: 26-Feb-2014
Journal of Experimental Medicine
Experimental treatment developed at UCLA eradicates acute leukemia in mice
A team of scientists from the University of California Los Angeles Jonsson Comprehensive Cancer Center has developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread.

Contact: Shaun Mason
University of California - Los Angeles

Public Release: 26-Feb-2014
Applied and Environmental Microbiology
Harvested rainwater harbors pathogens
South Africa has been financing domestic rainwater harvesting tanks in informal low-income settlements and rural areas in five of that nation's nine provinces. But pathogens inhabit such harvested rainwater, potentially posing a public health hazard, especially for children and immunocompromised individuals, according to a team from the University of Stellenbosch. The research was published ahead of print in Applied and Environmental Microbiology.

Contact: Jim Sliwa
American Society for Microbiology

Public Release: 26-Feb-2014
Health Affairs
Improved prescribing and reimbursement practices in China
Pay-for-performance has become a major component of health reforms in the United States, the United Kingdom, and other affluent countries. Although the approach has also become popular in the developing world, there has been little evaluation of its impact. A new study, released today as a Web First by Health Affairs, examines the effects of pay-for-performance, combined with capitation, in China's largely rural Ningxia Province.

Contact: Sue Ducat
Health Affairs

Public Release: 26-Feb-2014
New England Journal of Medicine
Febrile illnesses in children most often due to viral infections
Most children ill with fever in Tanzania suffer from a viral infection. A research team led by Dr. Valerie D'Acremont from the Swiss Tropical and Public Health Institute in Basel systematically assessed the causes of febrile illnesses in Tanzanian children. According to the results, in most cases a treatment with antimalarials or antibiotics is not required. The finding has the potential to improve the rational use of antimicrobials, and thus reduce costs and drug resistance.

Contact: Christian Heuss
Swiss Tropical and Public Health Institute

Public Release: 25-Feb-2014
Vinegar kills tuberculosis and other mycobacteria
The active ingredient in vinegar, acetic acid, can effectively kill mycobacteria, even highly drug-resistant Mycobacterium tuberculosis, an international team of researchers from Venezuela, France, and the US reports in mBio, the online open-access journal of the American Society for Microbiology.

Contact: Jim Sliwa
American Society for Microbiology

Public Release: 23-Feb-2014
A key protein is discovered as essential for malaria parasite transmission to mosquitos
Scientists studying the sexual transformation of the malaria parasite have solved a long-standing mystery in parasite biology. Two research teams have independently discovered that a single protein acts as the master genetic switch that triggers the development of male and female sexual forms of the malaria parasite. The discovery has important implications for human health.
National Institutes of Health, Damon Runyon Cancer Research Foundation, Wellcome Trust, European Comission, Biotechnology and Biological Sciences Research Council, Spanish Ministry of Science and Innovation, and others

Contact: Barbara K. Kennedy
Penn State

Public Release: 20-Feb-2014
Developing countries face 'leading medical scourge of developed countries'
Chronic illness, already a major and expensive problem in developed countries, is rapidly increasing in developing countries, adding to the longstanding burden caused by high rates of infectious diseases. However, poor countries will not be able to afford the costly medical technologies that wealthy countries use to treat chronic conditions, including heart disease, stroke, cancer, pulmonary disease, and diabetes, writes Daniel Callahan, cofounder of the Hastings Center.

Contact: Susan Gilbert
845-424-4040 x244
The Hastings Center

Showing releases 701-725 out of 1032.

<< < 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 > >>